my account log out | |
Anti-TACSTD2 (clone 7E6)-AcLys-VC-PABC-0101 |
Create: 04/27/2019 |
Expired Date: | never |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone 7E6) conjugated via a AcLys-VC-PABC linker to a drug. Due to its carcinogenic nature and cell surface localization, TACSTD2 has been exploited as a target for ADC-based immunotherapies. It is the target for antibody-drug conjugates such as sacituzumab govitecan, an ADC that bears SN38, a topoisomerase I inhibitor, for accurate cancer elimination.https://www.creative-biolabs.com/adc/target-tacstd2-93.htm |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
Feb 01 2023 | GVBE Buffer | 214 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 392 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 476 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 385 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 401 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 387 | |
Aug 30 2019 | Anti-EIAV env Antibody | 411 |
Copyright © toextrade Inc. All rights reserved. Contact us |